Home  /  Resource Library  /  Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience

Outcomes of Patients with Primary Mediastinal B-Cell Lymphoma Treated with Dose Adjusted R-EPOCH Regimen: A Single Centre Experience

Results of study examining dose adjusted chemoimmunotherapy for treatment of for first line primary mediastinal B-cell lymphoma.